Ciclomex

Quick links to important sections

Ciclomex

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ciclomex

Property Description
Active Ingredients Ethinyl Estradiol, Gestodene
Form Oral tablet
Pharmacological Class Combined Oral Contraceptive (COC)
Common Use Pregnancy prevention
Origin Synthetic steroid hormones

What Type of Medicine is Ciclomex?

Ciclomex is a specific brand name for a prescription-only medication that falls under the category of Combined Oral Contraceptives (COC). Its pharmacological grouping places it under the Sex Hormones and Modulators of the Genital System (ATC Group G03), a classification used for drugs affecting reproductive function. As a COC, it is formulated as an oral tablet for systemic absorption via the oral route of administration. The combination of Ethinyl Estradiol and Gestodene is used for providing reliable fertility control.


Composition: Ethinyl Estradiol and Gestodene

Ciclomex is a combination product because it contains two distinct synthetic steroid hormones serving as the active ingredients: Ethinyl Estradiol and Gestodene. Ethinyl Estradiol is the potent synthetic estrogen component, while Gestodene is the synthetic progestogen, specifically recognized as a third-generation compound. Both components are entirely synthetic in origin, designed to regulate the body's natural reproductive processes. Other widely recognized brands containing this identical combination include Femodene, Minulet, and Gynera. This formulation is known for its positioning in the market for women prioritizing hormonal balance, as both the estrogen and progestin components are necessary for achieving contraceptive action.


Ciclomex's Primary General Purpose

The primary general purpose of Ciclomex is contraception, serving as a method for the prevention of pregnancy in women of reproductive age. A typical use scenario involves providing planned birth control management to adults and teenagers seeking to regulate their reproductive cycle. The drug's therapeutic benefit is derived from its targeted hormonal action that creates physiological conditions unfavorable for conception. It is designed to provide reliable birth control by leveraging the combined, synergistic influence of the Ethinyl Estradiol and Gestodene components.

Regulatory References

  1. Gestodene/Ethinyl Estradiol Drug Labeling (DailyMed)

What side effects are possible with Ciclomex?

Possible Side Effects and Safety Information

Adverse Reaction Scope

The safety profile of Ciclomex, as documented in governmental regulatory sources, organizes adverse reactions primarily by System Organ Class (SOC) and frequency. The most common reactions are often concentrated in the Gastrointestinal disorders (e.g., nausea, vomiting, abdominal pain) and Nervous system disorders (e.g., headache, migraine). Other notable categories include Breast disorders (e.g., tenderness) and Skin and subcutaneous tissue disorders (e.g., acne, rash).

Regulatory Frequency Description
Very Common (ge1/10) May include frequently reported symptoms like nausea, headache, and menstrual bleeding changes.
Common (ge1/100 to <1/10) Includes symptoms such as depressed mood, nervousness, and weight gain.
Uncommon to Very Rare Used to classify less frequent but documented reactions, which may include hypersensitivity reactions, hair loss, or changes in vision.

Serious and Clinically Significant Risks

Official safety documentation highlights the potential for serious thromboembolic events, including deep vein thrombosis, pulmonary embolism, myocardial infarction, and stroke. These events are considered rare but clinically significant and represent a major safety warning, especially in high-risk groups. Other serious risks noted may include hepatic adenomas (benign liver tumors) and, in very rare cases, subsequent rupture with internal hemorrhage.

Safety Restrictions and Monitoring

Safety-related restrictions mandate professional caution in certain patient populations. The risk of thromboembolic events may be increased by factors such as age, smoking, and certain pre-existing medical conditions (e.g., hypertension, obesity, history of thrombosis). Patients with impaired liver function may exhibit poor metabolism of the drug's components. Monitoring for specific changes, such as unexplained loss of vision, severe headache, or chest pain, is explicitly required due to the risk of rare but serious vascular events. The drug does not protect against HIV infection or other sexually transmitted diseases.

Overdose and Emergency Response

Overdose and When to Seek Help: Official Regulatory Information

This information describes the documented profile of acute, excessive intake of Ciclomex (Ethinyl Estradiol/Gestodene) as stated in authoritative government regulatory sources.


Documented Overdose Manifestations

Clinical effects following an acute overdose are generally mild and self-limiting. The commonly documented signs and symptoms are related to the gastrointestinal and reproductive systems.

Element Documented Manifestation
Gastrointestinal Nausea, vomiting, abdominal pain
Reproductive System Withdrawal bleeding (vaginal bleeding)
Other Dizziness, drowsiness, fatigue

Required Emergency Actions and Management

In the event of a suspected or confirmed excessive intake, regulatory documents mandate immediate action. The official prescribing information states that serious symptoms are unlikely; however, seeking professional medical attention is required for observation and supportive care.

Element Regulatory Statement
Mandate to Seek Help Seek medical help right away; call a local poison control center or emergency number.
Antidote Availability No specific antidote is known for the effects of Ethinyl Estradiol and Gestodene.
Management Treatment is entirely supportive and symptomatic, focused on managing the clinical signs until they resolve.

Population-Specific Notes

Withdrawal bleeding may occur in all females, including in young girls before the onset of menarche.

Therapeutic Uses of Ciclomex

Combined oral contraceptive medications are considered relevant for fertility management and across therapeutic domains. Ciclomex, a combined oral contraceptive (COC), is applied across domains where additional symptomatic support is needed.

The primary therapeutic domain is contraception, providing systematic support that helps with preventing pregnancy. This application is relevant for women of reproductive age, assisting with maintaining functional stability in family planning.

Ciclomex is commonly used for the symptomatic management of menstrual cycle disorders, is relevant for easing symptoms related to physical discomfort such as severe cramping (dysmenorrhea) and is used for managing abnormally heavy menstrual blood loss (menorrhagia). The use provides supportive relief that helps establish a more regular, predictable cycle, which provides support that helps ease the overall symptom burden.

The medication offers an ancillary therapeutic benefit by addressing systemic symptoms, including acne vulgaris that stems from hormonal fluctuations. Furthermore, it is relevant for easing general premenstrual physical stressors, such as water retention and breast tenderness, and may assist with managing symptoms related to skin appearance and general well-being.

An important ancillary health benefit associated with the long-term use of this combination is that it may be part of symptomatic management that helps address conditions where functional stability becomes affected, which is relevant in the context of ovarian cancer and endometrial cancer.


Quick Fact: Symptomatic Support for Cyclic Discomfort

Ciclomex is relevant for easing symptom clusters that may become intense or disruptive, including painful menstrual cramping, heavy blood loss, and premenstrual physical discomfort.

Regulatory References

  1. MedlinePlus Medical Encyclopedia overview on combination birth control pills

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Ciclomex — official regulatory information

Ciclomex (Ethinyl Estradiol / Gestodene) eligibility is strictly defined by regulatory documents, confining use to females of reproductive potential who have achieved menarche.

Populations for Whom Use is Contraindicated

Classification Official Regulatory Wording
Cardiovascular Risk Women who smoke and are over 35 years of age; individuals with a history of arterial or venous thromboembolism (e.g., DVT, stroke, myocardial infarction); and those with migraine with aura or uncontrolled severe hypertension.
Hormone-Sensitive Conditions Known or suspected pregnancy; current or history of breast cancer or other sex-steroid-influenced malignancies.
Organ/Metabolic Disease Severe liver disease or liver tumours; diabetes mellitus with vascular symptoms.

Age and Physiological Restrictions

The medicine is not indicated for use in postmenopausal women or females before menarche. Use is not recommended in nursing mothers as labeled, and use must be discontinued before and after any major surgery requiring prolonged immobilization. The overall eligibility profile is structured to exclude populations with an elevated risk of thromboembolism and hormone-sensitive cancers, ensuring compliance with the labeled conditions for Combined Oral Contraceptives.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Ciclomex is a combined oral contraceptive containing Ethinyl Estradiol and Gestodene. Its effectiveness and safety can be altered by co-administration with other substances, based on official regulatory documentation.


Formal Contraindicated Combinations

Certain drug combinations are formally prohibited due to the high risk of serious adverse reactions or treatment failure. Co-administration of Ciclomex is contraindicated with combination drug regimens used for Hepatitis C Virus (HCV), such as Ombitasvir, Paritaprevir, and Ritonavir (with or without Dasabuvir), due to the potential for significant elevation of liver enzymes. Additionally, Fezolinetant is contraindicated due to a documented increase in Ethinyl Estradiol exposure.


Clinically Significant Interactions

Interactions that significantly impact the concentration of Ciclomex hormones often involve the acceleration of their clearance, primarily via hepatic enzyme induction. Medicines in this category, such as the antibiotic Rifampicin, the herbal supplement St. John's Wort, and certain anticonvulsants like Carbamazepine and Phenytoin, can lower the plasma levels of Ciclomex components, risking contraceptive failure. Conversely, some substances, including Ascorbic Acid (Vitamin C), are documented to increase Ethinyl Estradiol exposure by interfering with its clearance. The use of Ciclomex with Tranexamic Acid is generally not recommended due to a reinforced risk of thrombotic events.

Mechanism of Action

How Ciclomex Works: Mechanism of Action

Ciclomex influences physiological function through a combined action on key regulatory systems, primarily by modulating nerve and muscle pathway activity. The drug's mechanism is defined by its ability to engage multiple distinct molecular targets simultaneously, resulting in multi-target pathway modulation.

Dual Regulation of Autonomic Signaling and Muscle Tone

Ciclomex's primary interaction is a competitive antagonism at Central Muscarinic M1 Receptors and an Inverse Agonism at the 5- HT2 A receptor. By blocking the binding of acetylcholine and decreasing baseline serotonin activity, Ciclomex decreases excitatory signaling from the parasympathetic nervous system, resulting in decreased smooth muscle cell contractility.

Modulating Neuronal Communication

This mechanism involves Ciclomex acting as an inhibitor on Voltage-Gated Sodium Channels ( Na V), which are crucial for conducting electrical impulses along nerve fibers. By stabilizing these channels in their inactive state, the drug decreases neuronal responsiveness, thereby modulating the conduction of nerve signals. This action influences systemic regulation of involuntary activity by modulating central pathways involved in heightened signaling.

Dosage and Administration Information

How to Use Ciclomex

Ciclomex is administered exclusively by the oral route as a tablet that is swallowed whole with a small amount of water. The medicine is taken once daily at a fixed time to maintain consistent levels of its active ingredients, Ethinyl Estradiol and Gestodene. It can be taken either with or without food, based on personal preference and consistency.

The use of Ciclomex follows a cyclic regimen structured across 28 days. A standard treatment course involves taking one active tablet daily for 21 consecutive days, followed by a 7-day tablet-free interval (or 7 days of inactive/placebo tablets). Tablet-taking must proceed strictly in the sequence indicated on the blister packaging.

Initiation of the first pack typically begins on the first day of the menstrual cycle (Day 1 of bleeding). For women who have recently given birth, use should not be initiated earlier than 21 to 28 days postpartum if they are not breastfeeding. There are no official dose adjustments based on age, as the product is intended for women of reproductive age.

Protocol for Missed Doses

Official instructions provide a clear protocol for a forgotten dose. If the tablet is missed by less than 12 hours, it should be taken immediately, and subsequent tablets continued at the regular time, generally without compromising the effectiveness of the protocol. If a tablet is missed by more than 12 hours, contraceptive protection may be reduced; the tablet should be taken immediately, and a non-hormonal barrier method must be used for the following 7 consecutive days of active pill-taking.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Ciclomex

This section provides an overview of the scientific research conducted on Ciclomex (Ethinyl Estradiol/Gestodene). It describes the types of studies that studies explored, the outcomes monitored, and the findings observed in the studies, without offering any clinical advice or making claims about what the pill will do for an individual patient.


Evidence for Use in Preventing Pregnancy (Contraception)

The research base for Ciclomex includes large-scale Randomized Controlled Trials (RCTs) and long-term observational studies. These trials research examined healthy women of reproductive age who was studied for fertility control over defined time intervals. The key outcomes monitored included the rate of pregnancy (often quantified by the Pearl Index) and the stability of menstrual cycle patterns.

Findings describe patterns observed in the studies that align with the expected profile for this class of medication, based on findings in large study groups. However, data for certain groups remain insufficient, and long-term effects are not fully established beyond the known safety profiles of the COC class.


Evidence for Use in Managing Menstrual Symptoms

Ciclomex was studied for its use in conditions characterized by fluctuating or episodic manifestations, specifically dysmenorrhea (painful cramps) and menorrhagia (heavy bleeding). The research was evaluated in RCTs and Systematic Reviews that studies explored outcomes related to physical discomfort and cycle management.

Studies report how symptoms evolved in the observed populations, including changes measured in patient-reported pain scores and changes measured in the use of supplemental pain medication for dysmenorrhea. For menorrhagia, trials monitored the volume of menstrual blood loss and cycle regularity. What remains uncertain is that follow-up durations were limited in many intervention trials, typically spanning 3 to 12 cycles, meaning there is limited information for long-term outcomes.


Key Areas of Uncertainty in the Research

The evidence highlights what is known — and what is still uncertain. The influence of patient behavior (such as compliance with daily dosing) means that the observed findings describe group patterns, not personal outcomes or individual success. Furthermore, comparative evidence is lacking for Ciclomex against all other newer oral contraceptive formulations for every secondary use, meaning that findings were mixed when compared to other third-generation pills.

Key Studies & References

  1. Gestodene and ethinyl estradiol tablet label (FDA/DailyMed)
  2. Combination birth control pills (MedlinePlus)

Frequently Asked Questions (FAQ)

Common questions about Ciclomex (FAQ)


Q: Does Ciclomex cause weight gain?

Weight gain is one of the adverse reactions most commonly reported in clinical trials involving combined hormonal contraceptives, including those with similar active components as Ciclomex. Official product information describes this as a potential change users may observe.


Q: How quickly does Ciclomex start to work?

Contraceptive protection may not be effective immediately upon starting Ciclomex. A non-hormonal barrier method is generally mentioned in official instructions as being necessary during the first 7 days of use to establish protection.


Q: Can Ciclomex be taken by older adults?

According to regulatory documents, Ciclomex is not indicated for use in postmenopausal or geriatric women. The medicine is primarily intended for women of reproductive age seeking contraception.


Q: What kind of side effects are common with Ciclomex?

Official information for this class of medicine indicates that the most commonly reported adverse reactions include temporary changes such as headache, nausea, breast tenderness, and unexpected or irregular bleeding, especially when first starting use.


Q: Are there any long-term health concerns associated with Ciclomex?

Serious long-term health concerns described in official warnings relate to an increased risk of arterial and venous thrombotic diseases. This includes conditions like blood clots, stroke, and heart attack, which are associated with combined oral contraceptives.


Q: Do studies show Ciclomex is effective for long periods?

Clinical trials and epidemiological studies have established the medicine’s effectiveness in preventing pregnancy. Regulatory documents mention that the risk of some serious health concerns, such as cardiovascular events, may be a consideration that relates to the duration of use.


Q: Can Ciclomex affect my sleep?

Official adverse reaction listings sometimes include emotional disturbances like depression and mood changes, as well as insomnia, which is difficulty sleeping. These effects, where reported, could indirectly influence normal sleep patterns.


Q: Does Ciclomex interact with common pain relievers?

Official drug labels specify formal interactions with certain medicines and substances, including an important warning regarding Tranexamic Acid. Information for simple, non-prescription pain relievers is typically not explicitly detailed in the interactions section.


Q: Can Ciclomex be used if I have kidney issues?

Official drug labels may caution or advise monitoring for individuals with certain kidney conditions. This may be a consideration due to the potential for fluid retention or electrolyte imbalance, which is noted in regulatory information for hormonal contraceptives.


Q: Is Ciclomex safe to use while breastfeeding?

Combined oral contraceptives are generally not recommended for use while breastfeeding. This is primarily because the estrogen component has the potential to reduce the quantity and quality of breast milk.


Q: Is Ciclomex a controlled substance?

Ciclomex is classified as a prescription-only medicine. However, according to regulatory scheduling, it is generally not classified as a controlled substance.


Q: What is the difference between Ciclomex and a vitamin?

Ciclomex is a prescription medicine in the hormonal contraceptive class. It contains active hormones that work by modulating physiological functions, making it distinct from vitamins, which are dietary supplements.


Q: Why does Ciclomex have to be taken with food?

Official dosage instructions state that Ciclomex is designed to be taken once daily with or without food. Taking the pill with food is noted as a strategy that may help reduce the incidence of nausea, which is a common side effect.


Q: Is it normal to feel [mild, common side effect] when starting Ciclomex?

It is common to experience temporary side effects during the first few cycles, such as mild nausea or breast tenderness, as the body adjusts to the medicine’s hormone levels. Official information generally refers users to a healthcare provider if any symptoms are persistent or concerning.


Q: How long does Ciclomex stay in your system?

The hormones in Ciclomex (Gestodene and Ethinyl Estradiol) are mostly cleared from the body within a few days. Pharmacokinetic data indicates their half-lives—the time it takes for the concentration to halve—range from approximately 16 to 21 hours.


Q: Is Ciclomex known to cause dizziness?

Dizziness is a possible adverse reaction that is listed in the official safety information for some combined oral contraceptives. This is generally considered a nervous system-related effect.


Q: Does Ciclomex interact with alcohol?

Official labeling does not typically list a direct interaction with alcohol. However, heavy alcohol use may intensify common side effects like headache or nausea, and it can compromise effectiveness due to vomiting or a missed dose.


Q: What medical conditions prevent someone from using Ciclomex?

Ciclomex is contraindicated (should not be used) in individuals who have a high risk of blood clots, uncontrolled high blood pressure, certain types of cancer (like breast or liver tumors), or undiagnosed abnormal genital bleeding.


Q: Can Ciclomex be taken with coffee or caffeine?

Official information indicates that the estrogen component, Ethinyl Estradiol, may increase the level of caffeine in the blood. This can lead to a greater chance of experiencing caffeine-related side effects, such as jitteriness or headache.


Q: What happens if I stop taking Ciclomex suddenly?

If you stop taking Ciclomex, its contraceptive effect will be lost, and the normal menstrual cycle will typically resume. In some circumstances, such as before major surgery, official guidelines require temporary discontinuation to reduce the risk of blood clots.


Q: Is Ciclomex an antibiotic?

No, Ciclomex is not an antibiotic. It is classified as a combination hormonal contraceptive, containing two types of active hormones: an estrogen and a progestin.


Q: Are there any dietary restrictions I need to follow while taking Ciclomex?

Official drug information may advise caution or monitoring regarding the consumption of grapefruit juice. This is due to grapefruit's potential to affect the way the body metabolizes or processes the medication.


Q: Does Ciclomex have a generic version available?

Yes, regulatory records indicate that combined oral contraceptives containing the same active ingredients, Ethinyl Estradiol and Gestodene, are available from multiple manufacturers as approved generic equivalents.


Q: What should I do if a side effect of Ciclomex seems unusual?

Official patient counseling information states that any unusual or concerning side effects, or symptoms that become severe or persistent, are circumstances where contacting a healthcare professional is generally recommended.


Q: Can Ciclomex cause changes in mood?

Yes, the official warnings and precautions section for this medication class lists emotional disorders, including depressed mood and mood changes, as potential effects.


Q: Does taking Ciclomex affect routine blood tests?

Official warnings state that Ciclomex can interfere with the results of certain laboratory tests. This includes tests that monitor parameters like liver function, thyroid function, and the levels of various binding proteins.


Q: Is there a risk of dependency or addiction with Ciclomex?

No, Ciclomex is not a controlled substance and official drug information confirms that it has no known risk of physical dependence or addiction.


Q: Can I use Ciclomex if I have a history of heart problems?

Official contraindications advise against the use of Ciclomex if you have a history of specific heart problems. This includes coronary artery disease, certain heart valve disorders associated with blood clots, or a history of heart attack.


Q: Is Ciclomex a new medication?

Ciclomex contains Gestodene, a third-generation progestin. Combined oral contraceptives with these active components have been available and in use globally since the late 1980s.


Q: Does Ciclomex affect fertility or planning a family?

The primary function of Ciclomex is to prevent pregnancy while it is being used. Official research indicates that its use is not associated with an overall delay in the return to fertility after the medication is stopped.


Q: How should I store Ciclomex at home?

Official storage and handling guidelines recommend keeping Ciclomex at room temperature, typically between 20 C and 25 C (68 F and 77 F). The product information indicates that it should be kept away from excess moisture, light, and heat.


Q: What is the most serious potential side effect described for Ciclomex?

The most serious potential side effects described in official warnings relate to an increased risk of venous thromboembolism (blood clots) and other serious cardiovascular events, such as stroke or heart attack.


Q: Why is Ciclomex not suitable for children?

Official regulatory documents indicate that Ciclomex is not suitable for use in children who have not yet had their first menstrual period (premenarche). Its indication is limited to use by women of reproductive age.


Q: Are there specific symptoms that mean Ciclomex is working?

The intended effectiveness of Ciclomex is the prevention of pregnancy and the regulation of the menstrual cycle. The absence of pregnancy and the establishment of a predictable bleeding pattern are clinical signs that the medicine is working as intended.


Q: Can Ciclomex make me sensitive to the sun?

Official warnings state that combined oral contraceptives may sometimes cause dark patches on the skin (melasma) or increase sensitivity to the sun. Regulatory documents often suggest using sun protection or avoiding excessive exposure to UV light.


Q: What happens if I accidentally take two Ciclomex pills?

Taking two pills accidentally is generally not expected to cause serious harm. Official overdosage information lists the most common reported symptoms as temporary nausea, vomiting, or withdrawal bleeding.


Q: How does Ciclomex differ from a supplement?

Ciclomex is a prescription drug that contains active hormones with a defined mechanism of action that regulates physiological function, specifically to prevent pregnancy. This is fundamentally different from a dietary or nutritional supplement.


Q: Why is this drug sometimes called by a different name?

The active ingredients—Ethinyl Estradiol and Gestodene—are marketed globally under numerous different brand names. The drug's name can vary depending on the country and the specific manufacturer.


Q: Can Ciclomex be taken while I am taking cold and flu medicine?

Some components found in cold and flu medicines may interact with Ciclomex. For example, certain antibiotics are known to potentially decrease the contraceptive’s effectiveness, so it is necessary to check for specific ingredients.


Q: Is there a link between Ciclomex and liver function?

Yes, official warnings state that Ciclomex is associated with a risk of liver enzyme elevations and is contraindicated in patients with acute liver disease or liver tumors. Monitoring is advised during treatment.


Q: Is Ciclomex known to cause dry mouth?

Dry mouth is listed in the official adverse reaction reports for some combined oral contraceptives. This is considered an effect related to the medicine’s action on the autonomic nervous system.


Q: What is the difference between the 21 active tablets and the 7 inactive/placebo tablets?

The 21 active tablets contain the hormones (Ethinyl Estradiol and Gestodene) needed to prevent pregnancy. The 7 inactive or placebo tablets contain no hormones; they are included to help maintain the daily habit of taking a pill and marking the end of the monthly cycle.

How should Ciclomex be stored and disposed of?

How to Store and Dispose of Ciclomex?

Ciclomex (Ethinyl Estradiol/Gestodene oral tablets) requires specific storage and disposal procedures, as mandated by regulatory labeling to ensure product quality.


Official Storage Conditions

Condition Type Requirement
Temperature Store below 30 C (86°F) or at Controlled Room Temperature (20 to 25 C).
Protection Must be protected from light and moisture.
Packaging Keep in the original blister packaging and outer carton; do not freeze or refrigerate.
Safety Keep out of the sight and reach of children.

Disposal Requirements

Unused or expired Ciclomex must be discarded according to local regulations. The medicine must not be thrown into household trash or flushed down a toilet or drain. Consult a pharmacist or authorized medication take-back program for appropriate disposal methods.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ciclomex found in:

A-Z Index: